CollPlant Biotechnologies (CLGN) Receivables - Accured (2021 - 2025)
Historic Receivables - Accured for CollPlant Biotechnologies (CLGN) over the last 5 years, with Q3 2025 value amounting to -$10000.0.
- CollPlant Biotechnologies' Receivables - Accured changed N/A to -$10000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$10000.0, marking a year-over-year change of. This contributed to the annual value of -$11000.0 for FY2024, which is 6071.43% up from last year.
- As of Q3 2025, CollPlant Biotechnologies' Receivables - Accured stood at -$10000.0.
- Over the past 5 years, CollPlant Biotechnologies' Receivables - Accured peaked at $6000.0 during Q2 2024, and registered a low of -$151000.0 during Q4 2021.
- Over the past 5 years, CollPlant Biotechnologies' median Receivables - Accured value was -$10500.0 (recorded in 2024), while the average stood at -$36375.0.
- Per our database at Business Quant, CollPlant Biotechnologies' Receivables - Accured skyrocketed by 6781.61% in 2023 and then plummeted by 21666.67% in 2025.
- Quarter analysis of 5 years shows CollPlant Biotechnologies' Receivables - Accured stood at -$151000.0 in 2021, then skyrocketed by 42.38% to -$87000.0 in 2022, then skyrocketed by 67.82% to -$28000.0 in 2023, then surged by 60.71% to -$11000.0 in 2024, then rose by 9.09% to -$10000.0 in 2025.
- Its Receivables - Accured stands at -$10000.0 for Q3 2025, versus -$7000.0 for Q2 2025 and -$3000.0 for Q1 2025.